Figure S1. Viral loads plotted for individual mice (A). The viral loads for each of the six BLT humanized mice infected with JRCSF from Figure 2A are plotted separately. (B) The viral loads for the six BLT humanized mice infected with JRCSFNefdd from Figure 2A are presented as individual plots. JRCSF infected mice are from four different cohorts and JRCSFNefdd infected mice are from five different cohorts. The cohorts were distributed as follows. Cohort 1—JRCSF 3, 4 and JRCSFNefdd 4,5; Cohort 2—JRCSF 2, and JRCSFNefdd 3; Cohort 3—JRCSF 1; Cohort 4—JRCSF 5, 6 and JRCSFNefdd 6; Cohort 5—JRCSFNefdd 2; Cohort 6—JRCSFNefdd 1
Control and PLX5622-treated CNS tissue are equally permissive to WNV-NY infection. Mice were fed cho...
Dynamics of SHIV-KS661 and -#64 infection in HSC-F cells using nonlinear least-squares regression. W...
Influence of IL-2/anti-IL-2 mAb complex treatment on T cell subsets Mice were infected with 20.000 S...
Figure S2. Time course of T cell activation plotted for individual mice. (A) Individual JRCSF infect...
Figure S1. Integrated site of the transgene in NOG mouse genome. Figure S2. Human IL-34 expression i...
Figure S7. Profile of human cells in NSG-cmah−/− at 9 weeks post HIV-1 infection. NSG-cmah−/− mice w...
PLX5622 treatment does not impact T cell populations in peripheral immune compartments of uninfected...
PLX5622 treatment does not impact T cell activation in spleens of WNV-NS5-E218A infected mice. Mice ...
Impact of CSF1R antagonism on APC co-stimulatory expression is tissue-dependent. Mice were fed PLX56...
Figure S1. Human immune cell IGH gene CDR3 length frequency distribution in bone marrow. a Histogram...
Expression of Env and CD8-EnvCD 37 and 48 h post-transfection by Flow Cytometry. A. Expression of su...
Figure S1. Distribution of GFP in CNS of mice infected by lentivirus. The lentivirus suspension of L...
Figure S2. IgH CDR3 length in bone marrow and spleen in NSG-cmah−/− (m158, 103, 96, 159, 154) and NS...
PLX5622 treatment does not impact macrophage/monocyte population in peripheral immune compartments o...
Figure S5. Human TCRβ chain genes CDR3 size frequency distributions in spleen and repertoire charact...
Control and PLX5622-treated CNS tissue are equally permissive to WNV-NY infection. Mice were fed cho...
Dynamics of SHIV-KS661 and -#64 infection in HSC-F cells using nonlinear least-squares regression. W...
Influence of IL-2/anti-IL-2 mAb complex treatment on T cell subsets Mice were infected with 20.000 S...
Figure S2. Time course of T cell activation plotted for individual mice. (A) Individual JRCSF infect...
Figure S1. Integrated site of the transgene in NOG mouse genome. Figure S2. Human IL-34 expression i...
Figure S7. Profile of human cells in NSG-cmah−/− at 9 weeks post HIV-1 infection. NSG-cmah−/− mice w...
PLX5622 treatment does not impact T cell populations in peripheral immune compartments of uninfected...
PLX5622 treatment does not impact T cell activation in spleens of WNV-NS5-E218A infected mice. Mice ...
Impact of CSF1R antagonism on APC co-stimulatory expression is tissue-dependent. Mice were fed PLX56...
Figure S1. Human immune cell IGH gene CDR3 length frequency distribution in bone marrow. a Histogram...
Expression of Env and CD8-EnvCD 37 and 48 h post-transfection by Flow Cytometry. A. Expression of su...
Figure S1. Distribution of GFP in CNS of mice infected by lentivirus. The lentivirus suspension of L...
Figure S2. IgH CDR3 length in bone marrow and spleen in NSG-cmah−/− (m158, 103, 96, 159, 154) and NS...
PLX5622 treatment does not impact macrophage/monocyte population in peripheral immune compartments o...
Figure S5. Human TCRβ chain genes CDR3 size frequency distributions in spleen and repertoire charact...
Control and PLX5622-treated CNS tissue are equally permissive to WNV-NY infection. Mice were fed cho...
Dynamics of SHIV-KS661 and -#64 infection in HSC-F cells using nonlinear least-squares regression. W...
Influence of IL-2/anti-IL-2 mAb complex treatment on T cell subsets Mice were infected with 20.000 S...